Hollsteen
← Microchip

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: $85.0M · 10-Q 0000827054-15-000134 filed Aug 6, 2015Research and development · Q2 FY2016: $95.0M · 10-Q 0000827054-15-000218 filed Nov 9, 2015Research and development · Q3 FY2016: $97.0M · 10-Q 0000827054-16-000265 filed Feb 5, 2016Research and development · Q4 FY2016: $96.0M · derived · 10-K 0000827054-17-000098 filed May 30, 2017Research and development · Q1 FY2017: $148M · 10-Q 0000827054-16-000385 filed Aug 9, 2016Research and development · Q2 FY2017: $138M · 10-Q 0000827054-16-000472 filed Nov 8, 2016Research and development · Q3 FY2017: $132M · 10-Q 0000827054-17-000018 filed Feb 8, 2017Research and development · Q4 FY2017: $127M · derived · 10-K 0001628280-18-006982 filed May 18, 2018Research and development · Q1 FY2018: $130M · 10-Q 0000827054-18-000143 filed Aug 9, 2018Research and development · Q2 FY2018: $134M · 10-Q 0000827054-18-000249 filed Nov 7, 2018Research and development · Q3 FY2018: $132M · 10-Q 0000827054-19-000018 filed Feb 6, 2019Research and development · Q4 FY2018: $134M · derived · 10-K 0000827054-19-000143 filed May 30, 2019Research and development · Q1 FY2019: $172M · 10-Q 0000827054-18-000143 filed Aug 9, 2018Research and development · Q2 FY2019: $222M · 10-Q 0000827054-18-000249 filed Nov 7, 2018Research and development · Q3 FY2019: $218M · 10-Q 0000827054-19-000018 filed Feb 6, 2019Research and development · Q4 FY2019: $215M · derived · 10-K 0000827054-20-000119 filed May 22, 2020Research and development · Q1 FY2020: $219M · 10-Q 0000827054-19-000197 filed Aug 7, 2019Research and development · Q2 FY2020: $220M · 10-Q 0000827054-19-000288 filed Nov 6, 2019Research and development · Q3 FY2020: $217M · 10-Q 0000827054-20-000029 filed Feb 4, 2020Research and development · Q4 FY2020: $222M · derived · 10-K 0000827054-21-000106 filed May 18, 2021Research and development · Q1 FY2021: $198M · 10-Q 0000827054-20-000186 filed Aug 4, 2020Research and development · Q2 FY2021: $200M · 10-Q 0000827054-20-000278 filed Nov 5, 2020Research and development · Q3 FY2021: $210M · 10-Q 0000827054-21-000025 filed Feb 4, 2021Research and development · Q4 FY2021: $228M · derived · 10-K 0000827054-22-000094 filed May 20, 2022Research and development · Q1 FY2022: $238M · 10-Q 0000827054-21-000187 filed Aug 3, 2021Research and development · Q2 FY2022: $246M · 10-Q 0000827054-21-000280 filed Nov 4, 2021Research and development · Q3 FY2022: $245M · 10-Q 0000827054-22-000025 filed Feb 3, 2022Research and development · Q4 FY2022: $259M · derived · 10-K 0000827054-23-000080 filed May 25, 2023Research and development · Q1 FY2023: $269M · 10-Q 0000827054-22-000148 filed Aug 2, 2022Research and development · Q2 FY2023: $269M · 10-Q 0000827054-22-000193 filed Nov 3, 2022Research and development · Q3 FY2023: $282M · 10-Q 0000827054-23-000020 filed Feb 2, 2023Research and development · Q4 FY2023: $298M · derived · 10-K 0000827054-24-000098 filed May 23, 2024Research and development · Q1 FY2024: $298M · 10-Q 0000827054-23-000132 filed Aug 3, 2023Research and development · Q2 FY2024: $293M · 10-Q 0000827054-23-000185 filed Nov 2, 2023Research and development · Q3 FY2024: $266M · 10-Q 0000827054-24-000024 filed Feb 1, 2024Research and development · Q4 FY2024: $240M · derived · 10-K 0000827054-25-000077 filed May 23, 2025Research and development · Q1 FY2025: $242M · 10-Q 0000827054-24-000139 filed Aug 1, 2024Research and development · Q2 FY2025: $241M · 10-Q 0000827054-24-000206 filed Nov 5, 2024Research and development · Q3 FY2025: $246M · 10-Q 0000827054-25-000019 filed Feb 6, 2025Research and development · Q4 FY2025: $255M · derived · 10-K 0000827054-26-000016 filed May 21, 2026Research and development · Q1 FY2026: $256M · 10-Q 0000827054-25-000133 filed Aug 7, 2025Research and development · Q2 FY2026: $262M · 10-Q 0000827054-25-000183 filed Nov 6, 2025Research and development · Q3 FY2026: $274M · 10-Q 0000827054-26-000009 filed Feb 5, 2026Research and development · Q4 FY2026: $294M · derived · 10-K 0000827054-26-000016 filed May 21, 2026Research and development · Q1 FY2027: $309M · 10-Q 0000827054-26-000038 filed Aug 6, 202630985Q1 FY2016Q1 FY2027Q3 FY2021
$MResearch and development · Q2 FY2025: $241M · 10-Q 0000827054-24-000206 filed Nov 5, 2024Research and development · Q3 FY2025: $246M · 10-Q 0000827054-25-000019 filed Feb 6, 2025Research and development · Q4 FY2025: $255M · derived · 10-K 0000827054-26-000016 filed May 21, 2026Research and development · Q1 FY2026: $256M · 10-Q 0000827054-25-000133 filed Aug 7, 2025Research and development · Q2 FY2026: $262M · 10-Q 0000827054-25-000183 filed Nov 6, 2025Research and development · Q3 FY2026: $274M · 10-Q 0000827054-26-000009 filed Feb 5, 2026Research and development · Q4 FY2026: $294M · derived · 10-K 0000827054-26-000016 filed May 21, 2026Research and development · Q1 FY2027: $309M · 10-Q 0000827054-26-000038 filed Aug 6, 2026309241Q2 FY2025Q1 FY2027Q2 FY2026
Q1 FY2027
309$M
All values (45)
PeriodValue ($M)Status
Q1 FY2027309reported
Q4 FY2026294derived
Q3 FY2026274reported
Q2 FY2026262reported
Q1 FY2026256reported
Q4 FY2025255derived
Q3 FY2025246reported
Q2 FY2025241reported
Q1 FY2025242reported
Q4 FY2024240derived
Q3 FY2024266reported
Q2 FY2024293reported
Q1 FY2024298reported
Q4 FY2023298derived
Q3 FY2023282reported
Q2 FY2023269reported
Q1 FY2023269reported
Q4 FY2022259derived
Q3 FY2022245reported
Q2 FY2022246reported
Q1 FY2022238reported
Q4 FY2021228derived
Q3 FY2021210reported
Q2 FY2021200reported
Q1 FY2021198reported
Q4 FY2020222derived
Q3 FY2020217reported
Q2 FY2020220reported
Q1 FY2020219reported
Q4 FY2019215derived
Q3 FY2019218reported
Q2 FY2019222reported
Q1 FY2019172reported
Q4 FY2018134derived
Q3 FY2018132reported
Q2 FY2018134reported
Q1 FY2018130reported
Q4 FY2017127derived
Q3 FY2017132reported
Q2 FY2017138reported
Q1 FY2017148reported
Q4 FY201696derived
Q3 FY201697reported
Q2 FY201695reported
Q1 FY201685reported

CSV with all sources · Technical ID: rnd

More metrics for Microchip

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Gross profit by segment

Sources & calculation
Value
$309M
Period
Q1 FY2027, ended Jun 30, 2026 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Aug 6, 2026 · 0000827054-26-000038
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$309MAug 6, 202610-Q 0000827054-26-000038reported · confidence 1. · current